Hepatology

A new blood test accurately identifies serious scarring in patients with liver disease, a 2026 cohort study has found.

Since high levels of alanine aminotransferase are a significant biomarker of liver injury, this analysis points to the benefits of resistance exercise in patients with MASLD, which led to a noticeable decline in alanine aminotransferase levels.

A new point-of-care fingerstick test detects HBV within one hour, a 2026 diagnostic accuracy study has found.

Unscheduled care attendance data provides an opportunity to identify patients at high risk of liver disease, a 2026 study has found.

The risk of MASLD increases following menopause before the age of 50, according to a 2026 global cohort study.

Combining AI-processed CECT with clinical data improves the management of unresectable hepatocellular carcinoma, a 2026 study has found.

New data suggest MASLD overlap alters pruritus and fatigue severity in primary sclerosing cholangitis, with implications for symptom monitoring in hepatology practice.

Novel non-invasive liver disease assessments (NILDAs) are effective liver biopsy alternatives for fibrosis, a 2026 systematic review has found.